Food and Drug Administration

Anti-Viral Drugs Advisory Committee

March 19, 2002

Briefing Information

NDA 21-245 Picovirô (pleconaril) for treatment of acute picornaviral upper respiratory infection (common cold) in adults


The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

Sponsor - ViroPharma Incorporated   pdf

Food and Drug Administration   pdf   htm   doc